Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

4 Apr 2014 05:32

UK Dividends Calendar - Week Ahead

UK Dividends Calendar 
Read more
3 Apr 2014 15:41

UPDATE 1-Amgen ends marketing agreement with GSK for osteoporosis drug

(Adds details, background, GSK statement) April 3 (Reuters) - Amgen Inc said it would end an agreement with GlaxoSmithKline Plc for the marketing of its osteoporosis drug in some regions outside the United States. Amgen said it would take over the marketing of the drug, sold under the

Read more
3 Apr 2014 13:58

Amgen ends marketing agreement with GSK for osteoporosis drug

April 3 (Reuters) - Amgen Inc said it was ending an agreement with GlaxoSmithKline Plc, under which the British company marketed Amgen's postmenopausal osteoporosis drug in some regions outside the United States. Amgen said it would take over the marketing of the drug in areas under the agr

Read more
3 Apr 2014 10:58

UK doctors paid $64 mln by drug companies in 2013

LONDON, April 3 (Reuters) - Doctors in Britain were paid 38.5 million pounds ($64 million) by drugmakers last year, sightly less than 2012, according to new data underscoring the links between the pharmaceutical industry and prescribers. Industry payments to doctors have come under increase

Read more
3 Apr 2014 09:05

Thursday broker round-up UPDATE

Associated British Foods: Citi increases target price from 2350p to 3000p, while its neutral rating remains unchanged. Booker Group: Investec shifts target price from 172p to 178p retaining a buy recommendation. BSkyB: HSBC Holdings moves target price from 600p to 610p, while keeping its underweig

Read more
2 Apr 2014 17:15

London close: Markets may be underestimating deflation risks in euro area

- Stocks extend three-week high - ECB, US data ahead - Antofagasta unharmed by Chile quake techMARK 2,782.92 -0.04% FTSE 100 6,659.04 +0.10% FTSE 250 16,415.96 +0.05% The Footsie ended the day slightly in the blue after the release of largely in-line data on US manufacturing orders alongside a sli

Read more
2 Apr 2014 15:30

Fusion IP flies as new directors dip in

Shares in university intellectual property commercialisation group Frontier IP flew higher on Wednesday after new directors dipped in to buy shares. New James Fish, Finance Director, bought £28,000 worth of shares at 28p per share, while Non-Executive Director Michael Bourne pocketed £49,000 of sha

Read more
2 Apr 2014 15:14

MARKET PULSE-MannKind, Rubicon, Liquidity Services, Acceleron, gold stocks

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks made modest gains on Wednesday and the S&P 500 held near its record high of the prior

Read more
2 Apr 2014 13:35

REFILE-MARKET PULSE-MannKind, Apollo Education, Envivio, DFC Global, Agrium

(Corrects day of the week to Tuesday from Wednesday in Salesforce item) U.S. stocks were set for a flat open on Wednesday, indicating the S&P 500 will hold near its record high reached in the prior session, after data on the labor market was slightly below expectations. Dow Jones industrial avera

Read more
2 Apr 2014 13:22

Donors commit $240 mln to fight neglected tropical diseases

April 2 (Reuters) - Bill Gates, the World Bank and other donors are stepping up efforts to fight neglected tropical diseases in Africa and other low-income regions with a $240 million injection of new funding. The new money follows a pledge by 13 drugmakers two years ago to donate medicines

Read more
2 Apr 2014 12:17

Broker tips: Glaxo, Centrica, FirstGroup, ASOS

Panmure Gordon has said that the disappointing outcome of GlaxoSmithKline's (GSK) clinical trial for its therapeutic cancer vaccine MAGE-A3 is already priced into the stock. Panmure said that MAGE-A3 could have been one of the "three particularly transformative pipeline opportunities". However, giv

Read more
2 Apr 2014 11:57

UK MIDDAY BRIEFING: Marks & Spencer Unveils Global Growth Plan

LONDON (Alliance News) - Marks and Spencer Group PLC is planning to open 250 new stores outside the UK over the next three years, as part of its global expansion plans.

M&S currently operates a total of 455 stores in 53 territories outside the UK, as well as nin

Read more
2 Apr 2014 11:48

London midday: Markets edge higher but gains limited

- Stocks extend three-week high - ECB, US data ahead - Antofagasta unharmed by Chile quake - Sports Direct extends gains on expansion potential techMARK 2,795.73 +0.42% FTSE 100 6,666.62 +0.21% FTSE 250 16,470.77 +0.39% The FTSE 100 had pushed into positive territory by Wednesday lunchtime, but ga

Read more
2 Apr 2014 11:30

DIRECTOR DEALINGS: Glaxo Non-Executives Awarded Shares, ADSs

LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a group of non-executives was awarded shares and American Depositary Shares at GBP16.08 per share and USD53.75 each respectively Monday.

Details are as follows.

Read more
2 Apr 2014 10:47

UK WINNERS & LOSERS: Marks & Spencer Rises On Expansion Plans

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Marks and Spencer Group, up 2.4%. The retailer has announced that it is planning to ope

Read more

Quickpicks are a member only feature

Login to your account